We report on 13 patients diagnosed with meningococcal infections in patients attending state-owned hospitals serving an indigent population in Pretoria in 2009. The case fatality rate was 27%. Ceftriaxone was the main antibiotic (9 out of 13 patients) for therapy. Five isolates (39%) were serogroup B and 4 (31%) serogroup W135. Most isolates (12/13) were fully susceptible to penicillin (MIC range 0.016 - 0.047 g/ml). A single isolate was intermediately resistant to penicillin (MIC, 0.125 g/ml) while all isolates were uniformly susceptible to ceftriaxone, ciprofloxacin and rifampicin. This pattern reveals a shift in serogroups with an increase of serogroup B disease in the Pretoria region, and the need for ongoing monitoring of antimicrobial...
Background. Antimicrobial treatment and chemoprophylaxis of patients and their close contacts is cri...
BACKGROUND: Study of meningococcal carriage is essential to understanding the epidemiology of Neisse...
BACKGROUND: The epidemiology of meningococcal disease in Mozambique and other African countries loca...
Aims: To ascertain whether isolates of Neisseria meningitidis in South Australia (SA) have become le...
Objective. To describe a Neisseri.a meningitidis outbreak in Gauteng during the period 1 July to 31 ...
Although relatively rare, meningococcal disease represents a global health problem being still the l...
BACKGROUND: Neisseria meningitidis (N. meningitidis) remains the leading worldwide cause of acute ba...
Background. In the African meningitis belt, Neisseria meningitidis serogroup W135 has emerged as a c...
Despite our improved understanding of the epidemiological fea-tures, pathogenesis, risk factors and ...
Meningoccocal disease has repeatedly caused outbreaks worldwide. There has been sudden surge of case...
Use of recently licensed vaccines against Neisseria meningitidis serogroup B (NmB) will depend partl...
Background: Neisseria meningitidis (N. meningitidis) remains the leading worldwide cause of acute...
Neisseria meningitidis is a major cause of bacterial meningitis and septicaemia worldwide and is ass...
Background: Neisseria meningitidis (N. meningitidis) remains the leading worldwide cause of ac...
Infection with the meningococcus is one of the main causes of meningitis and septicaemia worldwide. ...
Background. Antimicrobial treatment and chemoprophylaxis of patients and their close contacts is cri...
BACKGROUND: Study of meningococcal carriage is essential to understanding the epidemiology of Neisse...
BACKGROUND: The epidemiology of meningococcal disease in Mozambique and other African countries loca...
Aims: To ascertain whether isolates of Neisseria meningitidis in South Australia (SA) have become le...
Objective. To describe a Neisseri.a meningitidis outbreak in Gauteng during the period 1 July to 31 ...
Although relatively rare, meningococcal disease represents a global health problem being still the l...
BACKGROUND: Neisseria meningitidis (N. meningitidis) remains the leading worldwide cause of acute ba...
Background. In the African meningitis belt, Neisseria meningitidis serogroup W135 has emerged as a c...
Despite our improved understanding of the epidemiological fea-tures, pathogenesis, risk factors and ...
Meningoccocal disease has repeatedly caused outbreaks worldwide. There has been sudden surge of case...
Use of recently licensed vaccines against Neisseria meningitidis serogroup B (NmB) will depend partl...
Background: Neisseria meningitidis (N. meningitidis) remains the leading worldwide cause of acute...
Neisseria meningitidis is a major cause of bacterial meningitis and septicaemia worldwide and is ass...
Background: Neisseria meningitidis (N. meningitidis) remains the leading worldwide cause of ac...
Infection with the meningococcus is one of the main causes of meningitis and septicaemia worldwide. ...
Background. Antimicrobial treatment and chemoprophylaxis of patients and their close contacts is cri...
BACKGROUND: Study of meningococcal carriage is essential to understanding the epidemiology of Neisse...
BACKGROUND: The epidemiology of meningococcal disease in Mozambique and other African countries loca...